Clinical features and surgical selection in colitis-associated colorectal cancer with ulcerative colitis.
Cancer
Dysplasia
Refractory
Surgical treatment
Ulcerative colitis
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
28 Aug 2023
28 Aug 2023
Historique:
received:
02
05
2023
accepted:
19
08
2023
medline:
31
8
2023
pubmed:
29
8
2023
entrez:
28
8
2023
Statut:
epublish
Résumé
The aim of this study was to compare the clinical characteristics of ulcerative colitis (UC) patients who underwent surgery for cancer/dysplasia with those who underwent surgery for refractory disease and to discuss the preoperative preparation for successful hand-sewn IPAA. Patients who underwent surgery for UC between January 2014 and December 2021 at Hyogo Medical University were included in the study. A total of 443 UC surgical cases were included in the study, which comprised 188 cancer/dysplasia patients and 255 refractory patients. Clinical records were compared retrospectively. The proportion of surgical UC cases with cancer/dysplasia has been on the rise, accounting for approximately 40% in recent years. The duration of disease (months) was 186 (2-590) in the cancer/dysplasia group and 48 (1-580) in the refractory group (p = 0.02). UC severity (mild/moderate/severe) was 119/69/0 in the cancer/dysplasia group and 18/157/80 in the refractory group (p < 0.01). The four nutrition factors of weight (55.2 (32.7-99.6) kg: 49.9 (20.3-85.2) kg), body mass index (21.0 (13.9-32.5) kg/m2: 18.3 (11.4-34.1)kg/m2), serum albumin level (4.3 (2.7-5.0)g/dl: 3.4 (1.4-5.2)g/dl) and prognostic nutrition index (49.2 (33.2-61.2): 40.9 (17.4-61.1)) were significantly higher in the cancer/dysplasia group (p < 0.01). The degree of obesity was also significantly higher in the cancer/dysplasia group (p < 0.01). UC patients with cancer/dysplasia were more likely than refractory patients to have mild inflammation; they also had a longer duration of UC disease and better nutritional status.
Identifiants
pubmed: 37641118
doi: 10.1186/s12893-023-02160-x
pii: 10.1186/s12893-023-02160-x
pmc: PMC10463818
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
256Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54.e42; quiz e30.
doi: 10.1053/j.gastro.2011.10.001
pubmed: 22001864
Murakami Y, Nishiwaki Y, Oba MS, Asakura K, Ohfuji S, Fukushima W, et al. Estimated prevalence of ulcerative colitis and Crohn’s disease in Japan in 2014: an analysis of a nationwide survey. J Gastroenterol. 2019;54(12):1070–7.
Ikeuchi H, Uchino M, Matsuoka H, Bando T, Matsumoto T, Tomita N, et al. Surgery for ulcerative colitis in 1,000 patients. Int J Colorectal Dis. 2010;25(8):959–65.
doi: 10.1007/s00384-010-0915-8
pubmed: 20217422
Kaplan GG, Seow CH, Ghosh S, Molodecky N, Rezaie A, Moran GW, et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol. 2012;107(12):1879–87.
doi: 10.1038/ajg.2012.333
pubmed: 23165448
Rönnblom A, Holmström T, Tanghöj H, Karlbom U, Thörn M, Sjöberg D. Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005–2009. Scand J Gastroenterol. 2016;51(11):1339–44.
doi: 10.1080/00365521.2016.1200141
pubmed: 27356846
Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):746–74, 74.e1-4; quiz e12-3.
doi: 10.1053/j.gastro.2009.12.035
pubmed: 20141809
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–35.
doi: 10.1136/gut.48.4.526
pubmed: 11247898
pmcid: 1728259
Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg. 2007;94(3):333–40.
doi: 10.1002/bjs.5464
pubmed: 17225210
Lovegrove RE, Constantinides VA, Heriot AG, Athanasiou T, Darzi A, Remzi FH, et al. A comparison of hand-sewn versus stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy: a meta-analysis of 4183 patients. Ann Surg. 2006;244(1):18–26.
doi: 10.1097/01.sla.0000225031.15405.a3
pubmed: 16794385
pmcid: 1570587
Remzi FH, Fazio VW, Delaney CP, Preen M, Ormsby A, Bast J, et al. Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of prospective evaluation after a minimum of ten years. Dis Colon Rectum. 2003;46(1):6–13.
doi: 10.1007/s10350-004-6488-2
pubmed: 12544515
Horio Y, Uchino M, Bando T, Sasaki H, Goto Y, Kuwahara R, et al. Incidence, risk factors and outcomes of cancer of the anal transitional zone in patients with ulcerative colitis. J Crohns Colitis. 2020;14(11):1565–71.
doi: 10.1093/ecco-jcc/jjaa089
pubmed: 32365200
Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J. 1954;2(4884):375–8.
doi: 10.1136/bmj.2.4884.375
pubmed: 13182220
pmcid: 2078989
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85(9):1001–5.
pubmed: 6438478
Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7(1):1–33.
doi: 10.1016/j.crohns.2012.09.005
pubmed: 23040453
Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53(3):305–53.
doi: 10.1007/s00535-018-1439-1
pubmed: 29429045
pmcid: 5847182
Watanabe T, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Nakase H, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology. 2016;151(6):1122–30.
doi: 10.1053/j.gastro.2016.08.002
pubmed: 27523980
Øresland T, Bemelman WA, Sampietro GM, Spinelli A, Windsor A, Ferrante M, et al. European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis. 2015;9(1):4–25.
doi: 10.1016/j.crohns.2014.08.012
pubmed: 25304060
Hata K, Anzai H, Ikeuchi H, Futami K, Fukushima K, Sugita A, et al. Surveillance colonoscopy for ulcerative colitis-associated colorectal cancer offers better overall survival in real-world surgically resected cases. Am J Gastroenterol. 2019;114(3):483–9.
doi: 10.14309/ajg.0000000000000117
pubmed: 30747769
Ni A, Al-Qahtani M, Salama E, Marinescu D, Khalil MA, Faria J, et al. Trends in colectomies for colorectal neoplasms in ulcerative colitis: a national inpatient sample database analysis over two decades. J Gastrointest Surg. 2020;24(8):1721–8.
doi: 10.1007/s11605-020-04666-8
pubmed: 32557016
Matsubara N, Miyata H, Gotoh M, Tomita N, Baba H, Kimura W, et al. Mortality after common rectal surgery in Japan: a study on low anterior resection from a newly established nationwide large-scale clinical database. Dis Colon Rectum. 2014;57(9):1075–81.
doi: 10.1097/DCR.0000000000000176
pubmed: 25101603
Alizadeh RF, Moghadamyeghaneh Z, Whealon MD, Hanna MH, Mills SD, Pigazzi A, et al. Body mass index significantly impacts outcomes of colorectal surgery. Am Surg. 2016;82(10):930–5.
doi: 10.1177/000313481608201015
pubmed: 27779976
Govaert JA, Lijftogt N, van Dijk WA, Tseng LN, Liem RS, Tollenaar RA, et al. Colorectal cancer surgery for obese patients: Financial and clinical outcomes of a Dutch population-based registry. J Surg Oncol. 2016;113(5):489–95.
doi: 10.1002/jso.24187
pubmed: 26843323